$RFL News Article - European Medicines Agency Grants Orphan Drug Designation to Cornerstone Pharmaceuticals' CPI-613 (Devimistat) for Treatment of Patients with Advanced Unresectable Biliary Tract Cancer
https://marketwirenews.com/news-releases/euro...31974.html